3Lothar Thomas.Clinical Laboratory Diagnostics English Edition,1998:1277-1281.
4Chien DY,Arcangel P,Medina-Selby A,et al.Use of a novel hepatitis C virus(HCV) major-epitope chimeric polypeptide for diagnosis of HCV infection.J Clin Microbiol,1999,37(5):1393-1397.
5D.Robert Dufour,Mageli Talastas,Maria DA,et al.Chemiluminescence assay improves specificity of hepatitis C antibody detection.Clini Chem,2003,49(6):940-944.
6Strader DB,Wright T,Thomas D,et al.Diagnosis management and treatment of hepatitis C.Hepatology,2004,39(4):1147-1171.
7Simmonds P.Viral heterogeneity of the hepatitis C virus.J Hepatol,1999,31(Suppl 1):54-60.
10Dow BC,Munro I,Follett EAC,et al.Third-generation recombinant immunoblot assay:comparison of reactivities according to hepatitis C virus genotype.Transfusion,1996,36:547-551.
4[1]Chien DY,Arcangel P,Medina-Selby A, et al. Use of a novel hepatitis C virus (HCV)major-epitope chimeric polypeptide for diagnosis of HCV infection. J Clin Microbiol, 1999,37(5): 1393 ～ 1397
5Choo QL, Kuo G,Weiner AJ, et al.Science,1989.244-362.
6Huang ZH,Bouden S, Locarnini S.Detection of 5'-noncoding region of hepatitis C virus genome by ""nested"" polymerase chain reaction. Nanjing Yixueyuan xuebao,1992,12(6):215-219.
7Nakao T, Enomoto N, Takada N,Takada A,Date T.Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J Gen Virol,1991,72(3):2150-2112.
8Kanistanon D, Wongprompitak P, Dharakul T, et al. Hepatitis C virus nonstructural 3 protein : recombinant NS3 protein of the Thai isolates as an antigen in a diagnostic assay. Asian Pac J Allergy Immunol, 2002, 20:161-166.
9Aoyagi K, Ohue C, lida K, et al. Development of a simple and highly Sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol, 1999, 37: 1802-1808.
10Rodriguez-Lopez M, Riezu-Boj Jl, Ruiz M, et al. Immunogenicity of variable regions of hepatitis C virus proteins:selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA. J Gen Virol, 1999, 80: 727-738.
4Australian Government Department of Health and Ageing, Hepatitis C Subcommittee of the Ministerial Advisory Committee on AIDS,Sexual Health and Hepatitis, Blood Borne Virus and Sexually Transmissible Infections Subcommittee of the Australian Population Health Development Committee. National hepatitis C testing policy. 2007: 1-60.
5Alter M J, Kuhnert WL, Finelli L, et al. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Reeomm Rep, 2003, 52: 1-13, 15; quiz CE1-4.
6Blood safety and clinical technology, world health organization. Hepatitis c assays operational characteristic report 2, 2001: 1-44.
7National Health Service. Hepatitis C essential information for professionals and guidance on testing. 2004: 1-20.
8Carey W. Tests and screening strategies for the diagnosis of hepatitis C. Cleve Clin J Med, 2003, 70 Suppl 4: S7-S13.
9Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA, 2007, 297: 724-732.
10Davis GL. Monitoring of viral levels during therapy of hepatitis C. Hepatology, 2002, 36(5 suppl 1): S145-151.
